New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Investigators reveal changes to immune status in patient tumors after radiation

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors
Oncology January 30,2024
Investigators reveal changes to immune status in patient tumors after radiation

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors
Oncology January 30,2024
Researchers review the role of integrins in human hepatocellular carcinoma

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra
Oncology January 30,2024
Researchers review the role of integrins in human hepatocellular carcinoma

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra
Oncology January 30,2024
Oral sex is now the leading risk factor for throat cancer, says researcher

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha
Oncology January 30,2024
Oral sex is now the leading risk factor for throat cancer, says researcher

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha
Oncology January 30,2024
Researchers discover potential new melanoma treatment, giving hope to patients

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
Oncology January 30,2024
Researchers discover potential new melanoma treatment, giving hope to patients

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
Oncology January 30,2024
Creating a 'parts list' for cancer's spread, with help from a worm

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put
Oncology January 30,2024
Creating a 'parts list' for cancer's spread, with help from a worm

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put
Oncology January 30,2024
Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWomen with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to
Oncology January 30,2024
Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWomen with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to
Oncology January 30,2024
Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec
Oncology January 30,2024
Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec
Oncology January 30,2024
Research offers new approach to nongenetic T-cell-based immunotherapy

Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res
Oncology January 30,2024
Research offers new approach to nongenetic T-cell-based immunotherapy

Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res
Oncology January 30,2024
Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le
Oncology January 30,2024
Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le
Oncology January 30,2024
Exceptional case of a patient who survived 12 tumors could lead to early cancer diagnosis and immunotherapy

Exceptional case of a patient who survived 12 tumors could lead to early cancer diagnosis and immunotherapy

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainAn exceptional cancer case is featured in a study published in the journalScience Advances. This individual fi
Oncology January 30,2024
Exceptional case of a patient who survived 12 tumors could lead to early cancer diagnosis and immunotherapy

Exceptional case of a patient who survived 12 tumors could lead to early cancer diagnosis and immunotherapy

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainAn exceptional cancer case is featured in a study published in the journalScience Advances. This individual fi
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com